Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
131M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
12.7K
-
Total reported value, excl. options
-
$47K
-
Value change
-
+$1K
-
Number of buys
-
1
-
Price
-
$4.76
Significant Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q4 2014
2 filings reported holding AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value as of Q4 2014.
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.7K shares
of 131M outstanding shares and own 0.01% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (2.55M shares), GREAT POINT PARTNERS LLC (2.49M shares), RA CAPITAL MANAGEMENT, LLC (2.47M shares), BAKER BROS. ADVISORS LP (728K shares), DEUTSCHE BANK AG\ (133K shares), Cheyne Capital Management (UK) LLP (90K shares), BANK OF MONTREAL /CAN/ (12.5K shares), ROYAL BANK OF CANADA (11.4K shares), Tower Research Capital LLC (TRC) (3.05K shares), and CITIGROUP INC (171 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.